================================================================================== Skip to main content

Research & Studies

Menu RESEARCH Research & Studies In Canadian courts, HIV Cancer patients continue to be the most persecuted disabled minority group. With charges like HIV Cancer Murder and HIV Cancer aggravated sexual assault, each offense faces a life sentence. Patients are not charged or convicted based on infecting anyone but rather on the failure of the patient to disclose their illness. However, scientifically, there exist subgroups of HIV Cancer patients that courts continue to ignore. “The first is long-term no progressors, patients that will never develop an infectious viral load. Secondly, patients who have been taking HIV Cancer medication for at least six months and therefore have an undetectable viral load. “Understanding of these groups continues to remain a mystery to the courts, police, and the general public. It is my goal to remove this mystery from the public, and aid in protecting future HIV Cancer patients and their families from further HIV Cancer criminalization. Until me, only one other case, R v. JTC, included science in his defense. Since my acquittal, 3 more HIV Cancer patients have been imprisoned for Non-disclosure Aggravated sexual assault. Like almost all previous convictions, they pled guilty to lessen the pre-trial custody time in prison and because they and their counsel were unaware of the scientific defenses that exist. At present, there are around 150 Canadian HIV Cancer patients sitting in jail for Non-disclosure. Over the decades, many scientific tools have been included in Police investigations and the criminal justice system. There was a time when palmistry and fingerprint science were seen as foolish, and yet today, they are essential elements in a criminal investigation. Undetectable = Uninfectable must become scientific court and public precedent. Leading HIV Cancer Undetectable Cases: R vs JTC Case,2013, HIV/Cancer undetectable patient. v. J.T.C., 2013 NSPC 105 (CanLII), <https://canlii.ca/t/g1vj3>, retrieved on 2024-08-06 R vs Carlisle Case, 2018, HIV/Cancer Undetectable patient. v. JTC This case was against a child who was born with HIV Cancer or contracted it as a child, like me. Police did a sting at his senior prom

Leading HIV Cancer Undetectable Cases:

R vs JTC Case,2013, HIV/Cancer undetectable patient.

  1. R v. J.T.C., 2013 NSPC 105 (CanLII), <https://canlii.ca/t/g1vj3>, retrieved on 2024-08-06

R vs Carlisle Case, 2018, HIV/Cancer Undetectable patient.

  1. R v. JTC This case was against a child who was born with HIV Cancer or contracted it as a child, like me.  Police did a sting at his senior prom and arrested him for non-disclosure to his prom date. At trial, courts ruled that Undetectable HIV Cancer patients should no longer be prosecuted in 2013, yet in 2017, I was charged. 

Disability Protection Legislation

 Accessible Canada Act (justice.gc.ca)

https://www.google.com/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiO3vWl6-GHAxXMHjQIHShdDUMQFnoECB0QAQ&url=https%3A%2F%2Flaws-lois.justice.gc.ca%2Feng%2Facts%2Fa-0.6%2Fpage-1.html&usg=AOvVaw3huqmS3btr24pIPqVbtkDx&opi=89978449

Links to latest science of undetectable viral load and latest Court Case precedents behind the criminalization of undetectable HIV/ Cancer patients.

HIV: Undetectable = Untransmittable (U=U) – Canada.ca

The science is clear: with HIV, undetectable equals untransmittable | National Institutes of Health (NIH)

In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable (U=U) concept as scientifically sound, say officials from the National Institutes of Health. U=U means that people living with HIV who achieve and maintain an undetectable viral load—the amount of HIV in the blood—by taking and adhering to antiretroviral therapy (ART) as prescribed cannot sexually transmit the virus to others. Writing in JAMA, officials from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) review the scientific evidence underlying U=U and discuss the implications of widespread acceptance of the message.

 Creation of National Anti-discrimination legislation for Undetectable HIV / Cancer patients.

Undetectable is Uninfectable

Truvada Class Action Lawsuit

TDF Class Action: Truvada, Viread, Atripla, Complera, Stribild (callkleinlawyers.com)

On April 19, 2021, Klein Lawyers filed a class action lawsuit on behalf of Canadians who were prescribed and consumed Viread, Truvada, Atripla, Complera, and/or Stribild in Canada. These five drugs are tenofovir disoproxil fumarate (“TDF”) based medications used for the prevention and treatment of HIV/AIDS. The lawsuit alleges that the maker of these drugs, Gilead, knew that there was a safer alternative (Tenofovir Alafenamide or “TAF”) and knowingly delayed and withheld the development, marketing, and sale of TAF-based medications to maximize their profit from sales of the TDF drugs.

Safe Chemotherapy With Cannabis Cannabinoids;

A Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (Cannabis sativa) | Journal of Natural Products (acs.org)

A Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (Cannabis sativa)

The latest research shows that Cannabis cannabinoids can be used for chemotherapy treatment for HIV Cancer, including but not limited to hexacannabitriol, Tetrahydracannabinoid Acid, and others. I have been using these safe chemotherapy molecules for decades.

Phytochemical analysis of mother liquors obtained from the crystallization of CBD from hemp (Cannabis sativa), guided by LC-MS/MS and molecular networking profiling and completed by isolation and NMR-based characterization of constituents, resulted in the identification of 13 Phytocannabinoids. Among them, anhydrocannabimovone (5), isolated for the first time as a natural product, and three new hydroxylated CBD analogs (1,2-dihydroxycannabidiol, 6, 3,4-dehydro-1,2-dihydroxycannabidiol, 7, and hexocannabitriol, 8) were obtained. Hexocannabitriol (8) potently modulated, in a ROS-independent way, the Nrf2 pathway, outperforming all other cannabinoids obtained in this study and qualifying as a potential new chemopreventive chemotype against cancer and other degenerative diseases.

Research & Studies

Menu RESEARCH Research & Studies In Canadian courts, HIV Cancer patients continue to be the most persecuted disabled minority group. With charges like HIV Cancer Murder and HIV Cancer aggravated sexual assault, each offense faces a life sentence. Patients are not charged or convicted based on infecting anyone but rather on the failure of the patient to disclose their illness. However, scientifically, there exist subgroups of HIV Cancer patients that courts continue to ignore. “The first is long-term no progressors, patients that will never develop an infectious viral load. Secondly, patients who have been taking HIV Cancer medication for at least six months and therefore have an undetectable viral load. “Understanding of these groups continues to remain a mystery to the courts, police, and the general public. It is my goal to remove this mystery from the public, and aid in protecting future HIV Cancer patients and their families from further HIV Cancer criminalization. Until me, only one other case, R v. JTC, included science in his defense. Since my acquittal, 3 more HIV Cancer patients have been imprisoned for Non-disclosure Aggravated sexual assault. Like almost all previous convictions, they pled guilty to lessen the pre-trial custody time in prison and because they and their counsel were unaware of the scientific defenses that exist. At present, there are around 150 Canadian HIV Cancer patients sitting in jail for Non-disclosure. Over the decades, many scientific tools have been included in Police investigations and the criminal justice system. There was a time when palmistry and fingerprint science were seen as foolish, and yet today, they are essential elements in a criminal investigation. Undetectable = Uninfectable must become scientific court and public precedent. Leading HIV Cancer Undetectable Cases: R vs JTC Case,2013, HIV/Cancer undetectable patient. v. J.T.C., 2013 NSPC 105 (CanLII), <https://canlii.ca/t/g1vj3>, retrieved on 2024-08-06 R vs Carlisle Case, 2018, HIV/Cancer Undetectable patient. v. JTC This case was against a child who was born with HIV Cancer or contracted it as a child, like me. Police did a sting at his senior prom

Leading HIV Cancer Undetectable Cases:

R vs JTC Case,2013, HIV/Cancer undetectable patient.

  1. R v. J.T.C., 2013 NSPC 105 (CanLII), <https://canlii.ca/t/g1vj3>, retrieved on 2024-08-06

R vs Carlisle Case, 2018, HIV/Cancer Undetectable patient.

  1. R v. JTC This case was against a child who was born with HIV Cancer or contracted it as a child, like me.  Police did a sting at his senior prom and arrested him for non-disclosure to his prom date. At trial, courts ruled that Undetectable HIV Cancer patients should no longer be prosecuted in 2013, yet in 2017, I was charged. 

Disability Protection Legislation

 Accessible Canada Act (justice.gc.ca)

Links to latest science of undetectable viral load and latest Court Case precedents behind the criminalization of undetectable HIV/ Cancer patients.

HIV: Undetectable = Untransmittable (U=U) – Canada.ca

The science is clear: with HIV, undetectable equals untransmittable | National Institutes of Health (NIH)

In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable (U=U) concept as scientifically sound, say officials from the National Institutes of Health. U=U means that people living with HIV who achieve and maintain an undetectable viral load—the amount of HIV in the blood—by taking and adhering to antiretroviral therapy (ART) as prescribed cannot sexually transmit the virus to others. Writing in JAMA, officials from NIH’s National Institute of Allergy and Infectious Diseases (NIAID) review the scientific evidence underlying U=U and discuss the implications of widespread acceptance of the message.

 Creation of National Anti-discrimination legislation for Undetectable HIV / Cancer patients.

Undetectable is Uninfectable

Truvada Class Action Lawsuit

TDF Class Action: Truvada, Viread, Atripla, Complera, Stribild (callkleinlawyers.com)

On April 19, 2021, Klein Lawyers filed a class action lawsuit on behalf of Canadians who were prescribed and consumed Viread, Truvada, Atripla, Complera, and/or Stribild in Canada. These five drugs are tenofovir disoproxil fumarate (“TDF”) based medications used for the prevention and treatment of HIV/AIDS. The lawsuit alleges that the maker of these drugs, Gilead, knew that there was a safer alternative (Tenofovir Alafenamide or “TAF”) and knowingly delayed and withheld the development, marketing, and sale of TAF-based medications to maximize their profit from sales of the TDF drugs.

Safe Chemotherapy With Cannabis Cannabinoids;

A Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (Cannabis sativa) | Journal of Natural Products (acs.org)

A Nrf-2 Stimulatory Hydroxylated Cannabidiol Derivative from Hemp (Cannabis sativa)

The latest research shows that Cannabis cannabinoids can be used for chemotherapy treatment for HIV Cancer, including but not limited to hexacannabitriol, Tetrahydracannabinoid Acid, and others. I have been using these safe chemotherapy molecules for decades.

Phytochemical analysis of mother liquors obtained from the crystallization of CBD from hemp (Cannabis sativa), guided by LC-MS/MS and molecular networking profiling and completed by isolation and NMR-based characterization of constituents, resulted in the identification of 13 Phytocannabinoids. Among them, anhydrocannabimovone (5), isolated for the first time as a natural product, and three new hydroxylated CBD analogs (1,2-dihydroxycannabidiol, 6, 3,4-dehydro-1,2-dihydroxycannabidiol, 7, and hexocannabitriol, 8) were obtained. Hexocannabitriol (8) potently modulated, in a ROS-independent way, the Nrf2 pathway, outperforming all other cannabinoids obtained in this study and qualifying as a potential new chemopreventive chemotype against cancer and other degenerative diseases.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop